SCHEMBL24004060

SCHEMBL24004060

Nc1ccc(C(=O)Nc2cc(Nc3ccncc3)ccn2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.72
▸ MAPT P10636 3/20 0.72
▸ ACVRL1 P37023 2/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ RAD52 P43351 1/20 0.51
▸ KMT2A Q03164 2/20 0.50
▸ NT5E P21589 1/20 0.50
▸ LMNA P02545 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ APEX1 P27695 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ DNMT1 P26358 2/20 0.48
▸ DNMT3A Q9Y6K1 1/20 0.48
▸ MITF O75030 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ ABL1 P00519 1/20 0.47
▸ BCR P11274 1/20 0.47
▸ ABL2 P42684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30232862 0.91 ACVRL1 (0.62) POLBMAPTACVRL1L3MBTL1KDM4E
SCHEMBL24003821 0.91 ACVRL1 (0.62) POLBMAPTACVRL1L3MBTL1KDM4E
SCHEMBL26322741 0.86 POLB (0.53) POLBMAPTL3MBTL1KMT2ALMNA
SCHEMBL24006426 0.85 ACVRL1 (0.53) POLBMAPTACVRL1NT5EJAK2
SCHEMBL12240504 0.84 POLB (1.00) POLBMAPTL3MBTL1KDM4ERAD52
SCHEMBL22793631 0.84 POLB (0.72) POLBMAPTL3MBTL1KDM4ERAD52
SCHEMBL22793719 0.83 POLB (0.76) POLBMAPTL3MBTL1KDM4ERAD52
SCHEMBL25821615 0.83 ACVRL1 (0.54) POLBMAPTACVRL1
SCHEMBL25822055 0.82 MAPT (0.74) POLBMAPTACVRL1L3MBTL1KDM4E
SCHEMBL24010281 0.81 MAPK8 (0.52) POLBMAPTACVRL1NT5EJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 — — US disclosed
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 — — US disclosed
WO-2021226517-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 — — WO disclosed
WO-2021226458-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR POLB 2552/4885MAPT 3962/4885ACVRL1 2070/4885
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA POLB 2233/4885MAPT 3976/4885ACVRL1 2666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback